Lotus Pharmaceutical (Taiwan) Buy Hold or Sell Recommendation
| 1795 Stock | TWD 281.50 4.00 1.40% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding Lotus Pharmaceutical Co is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Lotus Pharmaceutical Co given historical horizon and risk tolerance towards Lotus Pharmaceutical. When Macroaxis issues a 'buy' or 'sell' recommendation for Lotus Pharmaceutical Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Lotus Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Lotus and provide practical buy, sell, or hold advice based on investors' constraints. Lotus Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Lotus |
Execute Lotus Pharmaceutical Buy or Sell Advice
The Lotus recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Lotus Pharmaceutical Co. Macroaxis does not own or have any residual interests in Lotus Pharmaceutical Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Lotus Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Lotus Pharmaceutical Trading Alerts and Improvement Suggestions
| About 62.0% of the company shares are owned by insiders or employees |
Lotus Pharmaceutical Returns Distribution Density
The distribution of Lotus Pharmaceutical's historical returns is an attempt to chart the uncertainty of Lotus Pharmaceutical's future price movements. The chart of the probability distribution of Lotus Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Lotus Pharmaceutical Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Lotus Pharmaceutical returns is essential to provide solid investment advice for Lotus Pharmaceutical.
| Mean Return | 0.02 | Value At Risk | -2.7 | Potential Upside | 3.38 | Standard Deviation | 1.99 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Lotus Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Lotus Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Lotus Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Lotus Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Lotus stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.0024 | |
β | Beta against Dow Jones | 0.1 | |
σ | Overall volatility | 2.02 | |
Ir | Information ratio | -0.06 |
Lotus Pharmaceutical Volatility Alert
Lotus Pharmaceutical Co has relatively low volatility with skewness of 1.57 and kurtosis of 5.93. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Lotus Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Lotus Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Lotus Pharmaceutical Fundamentals Vs Peers
Comparing Lotus Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Lotus Pharmaceutical's direct or indirect competition across all of the common fundamentals between Lotus Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Lotus Pharmaceutical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Lotus Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Lotus Pharmaceutical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Lotus Pharmaceutical to competition |
| Fundamentals | Lotus Pharmaceutical | Peer Average |
| Return On Equity | 0.26 | -0.31 |
| Return On Asset | 0.11 | -0.14 |
| Profit Margin | 0.22 % | (1.27) % |
| Operating Margin | 0.31 % | (5.51) % |
| Current Valuation | 73.53 B | 16.62 B |
| Shares Outstanding | 262.04 M | 571.82 M |
| Shares Owned By Insiders | 61.63 % | 10.09 % |
| Shares Owned By Institutions | 10.54 % | 39.21 % |
| Price To Earning | 16.94 X | 28.72 X |
| Price To Book | 4.97 X | 9.51 X |
| Price To Sales | 4.31 X | 11.42 X |
| Revenue | 12.65 B | 9.43 B |
| Gross Profit | 5.64 B | 27.38 B |
| EBITDA | 2.93 B | 3.9 B |
| Net Income | 1.4 B | 570.98 M |
| Cash And Equivalents | 1.97 B | 2.7 B |
| Cash Per Share | 8.02 X | 5.01 X |
| Total Debt | 4.67 B | 5.32 B |
| Debt To Equity | 0.82 % | 48.70 % |
| Current Ratio | 1.93 X | 2.16 X |
| Book Value Per Share | 51.30 X | 1.93 K |
| Cash Flow From Operations | 119.66 M | 971.22 M |
| Earnings Per Share | 11.86 X | 3.12 X |
| Target Price | 297.67 | |
| Number Of Employees | 10 | 18.84 K |
| Beta | 0.72 | -0.15 |
| Market Capitalization | 70.1 B | 19.03 B |
| Total Asset | 21.22 B | 29.47 B |
| Z Score | 9.0 | 8.72 |
| Annual Yield | 0.01 % | |
| Net Asset | 21.22 B | |
| Last Dividend Paid | 1.93 |
Lotus Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Lotus . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Lotus Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell Lotus Pharmaceutical Co? Buying financial instruments such as Lotus Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Lotus Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Silver Thematic Idea Now
Silver
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.